Don’t miss the latest developments in business and finance.

Alembic Pharmaceuticals receives ANDA approval for Itraconazole Capsules

Last Updated : Dec 17 2016 | 12:02 AM IST

Connect with us

From USFDA

Alembic Pharmaceuticals announced that the Company has received its Abbreviated New Drug Application (ANDA) for Itraconazole Capsules, 100 mg.

Powered by Capital Market - Live News

Connect with us on WhatsApp

Also Read

Alembic Pharma gains after USFDA approval for itraconazole capsules

Alembic Pharmaceuticals gets ANDA approval for Zolmitriptan Orally Disintegrating Tablets

Alembic Pharmaceuticals gets ANDA approval for Telmisartan and Amlodipine Tablets

Alembic Pharmaceuticals receives tentative approval for Febuxostat Tablets

Glenmark Pharmaceuticals receives ANDA approval for Triamcinolone Acetonide Cream

First Published: Dec 16 2016 | 11:27 AM IST

Explore News

Next Story